Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$36.95 - $82.41 $426,735 - $951,753
-11,549 Closed
0 $0
Q1 2022

Apr 13, 2022

BUY
$55.7 - $145.79 $106,888 - $279,771
1,919 Added 19.93%
11,549 $879,000
Q4 2021

Jan 18, 2022

BUY
$135.05 - $182.59 $52,264 - $70,662
387 Added 4.19%
9,630 $1.43 Million
Q3 2021

Oct 13, 2021

SELL
$145.58 - $192.14 $20,526 - $27,091
-141 Reduced 1.5%
9,243 $1.35 Million
Q2 2021

Jul 16, 2021

BUY
$134.22 - $202.37 $347,495 - $523,935
2,589 Added 38.1%
9,384 $1.84 Million
Q1 2021

May 05, 2021

BUY
$140.25 - $196.86 $60,868 - $85,437
434 Added 6.82%
6,795 $1.23 Million
Q4 2020

Jan 13, 2021

BUY
$126.47 - $163.7 $804,475 - $1.04 Million
6,361 New
6,361 $901,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.